ThreeD Capital Inc. Announces Completion of Private Placement with Sariel Diagnostics Corp.

TORONTO, March 22, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that it has closed its previously announced private placement (the “Private Placement”) with Sariel Diagnostics Corp. (“Sariel”), a privately held corporation existing under the laws of the Province of British Columbia. As a result of the Private Placement, ThreeD has acquired 3,750,000 common shares of Sariel at a price of $0.02 per share. In consideration, ThreeD has issued an aggregate of 150,000 common shares of the Company at a deemed price of $0.50 per common share. No commission or finders’ fees were paid in connection with the Private Placement.

Read More

​